The takeover comes as sales of BMS's blood cancer drug Revlimid, its 3rd-largest revenue driver, withered in the face of generic rivals and its blockbuster Opdivo is also scheduled to face competition from generics later this decade.

The secret weapon for brokers and their clients is clear: address the needs of job seekers and attract top talent.

Small business owners now have a range of options depending on the number of employees, but it's essential to start early, leverage tax-advantaged retirement accounts, diversify investments and plan for an exit strategy.

Deloitte analysis indicates genders consume health care differently, with women seeking more care and treatment.

Exposures often lead business owners to cut the wrong expenses and avoid the right investment.

Using Blue Shield of California as a precedent, more health entities may scale back their reliance on their PBMs in favor of centers of excellence that provide specific services. But this new approach to pharmacy benefits needs an organized and connected way for information to be shared.

Ready or not, artificial intelligence has arrived and is a "really powerful tool that takes large bodies of text and information and creates a knowledge base," according to a recent National Institute on Retirement Security webinar.

In January, new federal rules will pose restrictions on how Medicare Advantage plans use algorithm tools that match patients with similar diagnoses and characteristics to make some coverage decisions.